TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Multicenter, Randomized, Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) Delivered Via a SelfDose (TM) Device in the Treatment of Subjects With Moderate to Severe Plaque-Type Psoriasis
Brief Summary: The purpose of the study is to evaluate the efficacy, safety, pharmacokinetics, immunogenicity, usability, and acceptability of guselkumab delivered using SelfDose device in participants with moderate to severe plaque-type psoriasis.


Options:
A: Arm Label: 80 mg Ixekizumab Auto-Injector; Type: EXPERIMENTAL; Interventions: Drug: Ixekizumab Auto-Injector | Arm Label: 80 mg Ixekizumab Prefilled Syringe; Type: EXPERIMENTAL; Interventions: Drug: Ixekizumab Prefilled Syringe | Intervention Type: DRUG; Name: Ixekizumab Auto-Injector; Assigned to Arm(s): 80 mg Ixekizumab Auto-Injector | Intervention Type: DRUG; Name: Ixekizumab Prefilled Syringe; Assigned to Arm(s): 80 mg Ixekizumab Prefilled Syringe
B: Arm Label: Anti-TNFa regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: etanercept | Arm Label: Anti IL12/23 regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: ustekinumab | Arm Label: Cyclosporine regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: cyclosporine | Arm Label: anti-interleukin 17 A regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Secukinumab | Arm Label: inhibitor of phosphodiesterase-4; Type: ACTIVE_COMPARATOR; Interventions: Drug: Apremilast | Intervention Type: DRUG; Name: etanercept; Assigned to Arm(s): Anti-TNFa regimen | Intervention Type: DRUG; Name: ustekinumab; Assigned to Arm(s): Anti IL12/23 regimen | Intervention Type: DRUG; Name: cyclosporine; Assigned to Arm(s): Cyclosporine regimen | Intervention Type: DRUG; Name: Secukinumab; Assigned to Arm(s): anti-interleukin 17 A regimen | Intervention Type: DRUG; Name: Apremilast; Assigned to Arm(s): inhibitor of phosphodiesterase-4
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Biological: ABT-874 | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Biological: etanercept | Arm Label: C; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: BIOLOGICAL; Name: ABT-874; Assigned to Arm(s): A | Intervention Type: BIOLOGICAL; Name: etanercept; Assigned to Arm(s): B | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): C
D: Arm Label: Group 1 (Guselkumab: Placebo); Type: EXPERIMENTAL; Interventions: Drug: Guselkumab, Drug: Placebo | Arm Label: Group 2 (Placebo: Guselkumab); Type: EXPERIMENTAL; Interventions: Drug: Guselkumab, Drug: Placebo | Intervention Type: DRUG; Name: Guselkumab; Assigned to Arm(s): Group 1 (Guselkumab: Placebo), Group 2 (Placebo: Guselkumab) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 1 (Guselkumab: Placebo), Group 2 (Placebo: Guselkumab)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Multicenter, Randomized, Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) Delivered Via a SelfDose (TM) Device in the Treatment of Subjects With Moderate to Severe Plaque-Type Psoriasis
Brief Summary: The purpose of the study is to evaluate the efficacy, safety, pharmacokinetics, immunogenicity, usability, and acceptability of guselkumab delivered using SelfDose device in participants with moderate to severe plaque-type psoriasis.


Options:
A: Arm Label: Placebo (Part A); Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo for risankizumab | Arm Label: Risankizumab 75 mg (Part A); Type: EXPERIMENTAL; Interventions: Drug: risankizumab, Drug: placebo for risankizumab | Arm Label: Risankizumab 150 mg (Part A); Type: EXPERIMENTAL; Interventions: Drug: risankizumab | Intervention Type: DRUG; Name: risankizumab; Assigned to Arm(s): Risankizumab 150 mg (Part A), Risankizumab 75 mg (Part A) | Intervention Type: DRUG; Name: placebo for risankizumab; Assigned to Arm(s): Placebo (Part A), Risankizumab 75 mg (Part A)
B: Intervention Type: DRUG; Name: etanercept; Assigned to Arm(s): N/A
C: Arm Label: Single-Arm, open-label extension trial; Type: OTHER; Interventions: Drug: Adalimumab | Intervention Type: DRUG; Name: Adalimumab; Assigned to Arm(s): Single-Arm, open-label extension trial
D: Arm Label: Group 1 (Guselkumab: Placebo); Type: EXPERIMENTAL; Interventions: Drug: Guselkumab, Drug: Placebo | Arm Label: Group 2 (Placebo: Guselkumab); Type: EXPERIMENTAL; Interventions: Drug: Guselkumab, Drug: Placebo | Intervention Type: DRUG; Name: Guselkumab; Assigned to Arm(s): Group 1 (Guselkumab: Placebo), Group 2 (Placebo: Guselkumab) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 1 (Guselkumab: Placebo), Group 2 (Placebo: Guselkumab)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Multicenter, Randomized, Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) Delivered Via a SelfDose (TM) Device in the Treatment of Subjects With Moderate to Severe Plaque-Type Psoriasis
Brief Summary: The purpose of the study is to evaluate the efficacy, safety, pharmacokinetics, immunogenicity, usability, and acceptability of guselkumab delivered using SelfDose device in participants with moderate to severe plaque-type psoriasis.


Options:
A: Arm Label: Placebo (Part A); Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo for risankizumab, Drug: placebo for ustekinumab | Arm Label: Ustekinumab (Part A); Type: ACTIVE_COMPARATOR; Interventions: Drug: placebo for risankizumab, Drug: ustekinumab | Arm Label: Risankizumab (Part A); Type: EXPERIMENTAL; Interventions: Drug: risankizumab, Drug: placebo for ustekinumab | Intervention Type: DRUG; Name: risankizumab; Assigned to Arm(s): Risankizumab (Part A) | Intervention Type: DRUG; Name: placebo for risankizumab; Assigned to Arm(s): Placebo (Part A), Ustekinumab (Part A) | Intervention Type: DRUG; Name: ustekinumab; Assigned to Arm(s): Ustekinumab (Part A) | Intervention Type: DRUG; Name: placebo for ustekinumab; Assigned to Arm(s): Placebo (Part A), Risankizumab (Part A)
B: Arm Label: Group 1 (Guselkumab: Placebo); Type: EXPERIMENTAL; Interventions: Drug: Guselkumab, Drug: Placebo | Arm Label: Group 2 (Placebo: Guselkumab); Type: EXPERIMENTAL; Interventions: Drug: Guselkumab, Drug: Placebo | Intervention Type: DRUG; Name: Guselkumab; Assigned to Arm(s): Group 1 (Guselkumab: Placebo), Group 2 (Placebo: Guselkumab) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 1 (Guselkumab: Placebo), Group 2 (Placebo: Guselkumab)
C: Arm Label: Ixekizumab; Type: EXPERIMENTAL; Interventions: Drug: Ixekizumab | Arm Label: Guselkumab; Type: EXPERIMENTAL; Interventions: Drug: Guselkumab, Drug: Placebo | Intervention Type: DRUG; Name: Ixekizumab; Assigned to Arm(s): Ixekizumab | Intervention Type: DRUG; Name: Guselkumab; Assigned to Arm(s): Guselkumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Guselkumab
D: Arm Label: Abatacept (30/10); Type: ACTIVE_COMPARATOR; Interventions: Drug: Abatacept | Arm Label: Abatacept (10/10); Type: ACTIVE_COMPARATOR; Interventions: Drug: Abatacept | Arm Label: Abatacept (3/3); Type: ACTIVE_COMPARATOR; Interventions: Drug: Abatacept | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Abatacept; Assigned to Arm(s): Abatacept (10/10), Abatacept (3/3), Abatacept (30/10) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by Text Message to Increase the Acceptability of Effective Contraception Among Young Women in Palestine
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone text message on the acceptability of effective contraception in Palestine. Woman aged 18-24 will be randomised to receive 0-3 text messages a day for 4 months (intervention) or a monthly text message not about contraception (control). Participants will complete a questionnaire at baseline and 4 month follow-up.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive instant messages, Other: Mobile phone app | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Mobile phone app | Intervention Type: BEHAVIORAL; Name: Contraceptive instant messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mobile phone app; Assigned to Arm(s): Control, Intervention
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: miPlan intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: miPlan intervention; Assigned to Arm(s): Intervention
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention A - Behavioural Regulation; Type: EXPERIMENTAL; Interventions: Other: Intervention A - Behavioural Regulation | Arm Label: Intervention B - Priority; Type: EXPERIMENTAL; Interventions: Other: Intervention B - Priority | Intervention Type: OTHER; Name: Intervention A - Behavioural Regulation; Assigned to Arm(s): Intervention A - Behavioural Regulation | Intervention Type: OTHER; Name: Intervention B - Priority; Assigned to Arm(s): Intervention B - Priority
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive text messages | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Text messages not about contraception | Intervention Type: BEHAVIORAL; Name: Contraceptive text messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Text messages not about contraception; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by Text Message to Increase the Acceptability of Effective Contraception Among Young Women in Palestine
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone text message on the acceptability of effective contraception in Palestine. Woman aged 18-24 will be randomised to receive 0-3 text messages a day for 4 months (intervention) or a monthly text message not about contraception (control). Participants will complete a questionnaire at baseline and 4 month follow-up.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive text messages | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Text messages not about contraception | Intervention Type: BEHAVIORAL; Name: Contraceptive text messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Text messages not about contraception; Assigned to Arm(s): Control
B: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS text message; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS text message | Arm Label: SMS text message + Peer Navigation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS text message + Peer Navigation | Intervention Type: BEHAVIORAL; Name: SMS text message; Assigned to Arm(s): SMS text message | Intervention Type: BEHAVIORAL; Name: SMS text message + Peer Navigation; Assigned to Arm(s): SMS text message + Peer Navigation
C: Arm Label: texting group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: text messages focused on smoking cessation and pregnancy | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: text messages focused on smoking cessation and pregnancy; Assigned to Arm(s): texting group
D: Arm Label: 1. One way SMS messages.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 2. Two Way SMS messages; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 3. One way automated calls.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 4.Two way interactive automated calls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 5. Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS messages and automated calls; Assigned to Arm(s): 1. One way SMS messages., 2. Two Way SMS messages, 3. One way automated calls., 4.Two way interactive automated calls

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by Text Message to Increase the Acceptability of Effective Contraception Among Young Women in Palestine
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone text message on the acceptability of effective contraception in Palestine. Woman aged 18-24 will be randomised to receive 0-3 text messages a day for 4 months (intervention) or a monthly text message not about contraception (control). Participants will complete a questionnaire at baseline and 4 month follow-up.


Options:
A: Arm Label: Personalized Reminder Texting (iTAB) + Psychoeducation; Type: EXPERIMENTAL; Interventions: Behavioral: individualized Texting for Adherence Building (iTAB) | Arm Label: Psychoeducation (CTRL); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychoeducation | Intervention Type: BEHAVIORAL; Name: individualized Texting for Adherence Building (iTAB); Assigned to Arm(s): Personalized Reminder Texting (iTAB) + Psychoeducation | Intervention Type: BEHAVIORAL; Name: Psychoeducation; Assigned to Arm(s): Psychoeducation (CTRL)
B: Arm Label: Fixed SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Fixed SMS, real-time monitoring | Arm Label: Triggered SMS, real-time monitoring; Type: EXPERIMENTAL; Interventions: Device: Triggered SMS, real-time monitoring | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Fixed SMS, real-time monitoring; Assigned to Arm(s): Fixed SMS, real-time monitoring | Intervention Type: DEVICE; Name: Triggered SMS, real-time monitoring; Assigned to Arm(s): Triggered SMS, real-time monitoring
C: Arm Label: social networking on mobile phone; Type: EXPERIMENTAL; Interventions: Other: social networking on mobile phone | Arm Label: no social networking on mobile phone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: social networking on mobile phone; Assigned to Arm(s): social networking on mobile phone
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive text messages | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Text messages not about contraception | Intervention Type: BEHAVIORAL; Name: Contraceptive text messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Text messages not about contraception; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by Text Message to Increase the Acceptability of Effective Contraception Among Young Women in Palestine
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone text message on the acceptability of effective contraception in Palestine. Woman aged 18-24 will be randomised to receive 0-3 text messages a day for 4 months (intervention) or a monthly text message not about contraception (control). Participants will complete a questionnaire at baseline and 4 month follow-up.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive text messages | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Text messages not about contraception | Intervention Type: BEHAVIORAL; Name: Contraceptive text messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Text messages not about contraception; Assigned to Arm(s): Control
B: Arm Label: Education & paper based calendar; Type: EXPERIMENTAL; Interventions: Behavioral: Education & paper based calendar | Arm Label: Education & SMS system; Type: EXPERIMENTAL; Interventions: Behavioral: Education & SMS system | Arm Label: Education & smart-phone application; Type: EXPERIMENTAL; Interventions: Behavioral: Education & smart-phone application | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Education & paper based calendar; Assigned to Arm(s): Education & paper based calendar | Intervention Type: BEHAVIORAL; Name: Education & SMS system; Assigned to Arm(s): Education & SMS system | Intervention Type: BEHAVIORAL; Name: Education & smart-phone application; Assigned to Arm(s): Education & smart-phone application
C: N/A
D: Arm Label: SMS reminder; Type: EXPERIMENTAL; Interventions: Other: SMS reminder | Arm Label: SMS reminder and Travel subsidy; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS reminder and Travel subsidy 2; Type: EXPERIMENTAL; Interventions: Other: SMS reminder, Other: Travel subsidy 2 | Intervention Type: OTHER; Name: SMS reminder; Assigned to Arm(s): SMS reminder, SMS reminder and Travel subsidy, SMS reminder and Travel subsidy 2 | Intervention Type: OTHER; Name: Travel subsidy; Assigned to Arm(s): SMS reminder and Travel subsidy | Intervention Type: OTHER; Name: Travel subsidy 2; Assigned to Arm(s): SMS reminder and Travel subsidy 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase the Acceptability of Effective Contraception Among Young People in Tajikistan
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on the acceptability of effective contraception in Tajikistan. Woman and men aged 16-24 will be randomised to have access to the Tajik Family Planning Alliance's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 months.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive app instant messages, Other: Mobile phone app | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Mobile phone app | Intervention Type: BEHAVIORAL; Name: Contraceptive app instant messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mobile phone app; Assigned to Arm(s): Control, Intervention
B: Arm Label: Mobile phone-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone-based intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile phone-based intervention; Assigned to Arm(s): Mobile phone-based intervention
C: Arm Label: Text and Voice Messages; Type: EXPERIMENTAL; Interventions: Behavioral: Text and Voice Messages | Arm Label: Interactive Phone Call; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Phone Call | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text and Voice Messages; Assigned to Arm(s): Text and Voice Messages | Intervention Type: BEHAVIORAL; Name: Interactive Phone Call; Assigned to Arm(s): Interactive Phone Call
D: Arm Label: ARM 1 = TEXT MESSAGING SUPPORT; Type: EXPERIMENTAL; Interventions: Drug: nPEP, Behavioral: Text Messaging Support | Arm Label: ARM 2 = NO TEXT MESSAGING SUPPORT; Type: EXPERIMENTAL; Interventions: Drug: nPEP | Arm Label: ARM 3 = NURSE-LED nPEP; Type: EXPERIMENTAL; Interventions: Drug: nPEP, Other: Nurse-Led nPEP | Arm Label: ARM 4 = ID PHYSICIAN-LED nPEP,; Type: ACTIVE_COMPARATOR; Interventions: Drug: nPEP | Intervention Type: DRUG; Name: nPEP; Assigned to Arm(s): ARM 1 = TEXT MESSAGING SUPPORT, ARM 2 = NO TEXT MESSAGING SUPPORT, ARM 3 = NURSE-LED nPEP, ARM 4 = ID PHYSICIAN-LED nPEP, | Intervention Type: BEHAVIORAL; Name: Text Messaging Support; Assigned to Arm(s): ARM 1 = TEXT MESSAGING SUPPORT | Intervention Type: OTHER; Name: Nurse-Led nPEP; Assigned to Arm(s): ARM 3 = NURSE-LED nPEP

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase the Acceptability of Effective Contraception Among Young People in Tajikistan
Brief Summary: This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on the acceptability of effective contraception in Tajikistan. Woman and men aged 16-24 will be randomised to have access to the Tajik Family Planning Alliance's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 months.


Options:
A: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive app instant messages, Other: Mobile phone app | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Mobile phone app | Intervention Type: BEHAVIORAL; Name: Contraceptive app instant messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mobile phone app; Assigned to Arm(s): Control, Intervention
C: Arm Label: SMS Reminder; Type: EXPERIMENTAL; Interventions: Other: SMS Reminder | Arm Label: Interactive Reminder; Type: EXPERIMENTAL; Interventions: Other: Interactive Reminder | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: SMS Reminder; Assigned to Arm(s): SMS Reminder | Intervention Type: OTHER; Name: Interactive Reminder; Assigned to Arm(s): Interactive Reminder
D: Arm Label: Text Messaging Intervention; Type: EXPERIMENTAL; Interventions: Other: Text Messaging Intervention | Arm Label: Standard Referral; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Referral | Intervention Type: OTHER; Name: Text Messaging Intervention; Assigned to Arm(s): Text Messaging Intervention | Intervention Type: OTHER; Name: Standard Referral; Assigned to Arm(s): Standard Referral

Answer: B